ClinicalTrials.gg
Not yet recruitingNCT07620886BITEUpdated Jun 2, 2026

Effects of Postprandial Walking and Resistance Snacking on Glucose Responses in Adults With Metabolic Syndrome

An interventional study of Postprandial walking and Brief resistance exercise snacks in Metabolic Syndrome and Prediabetes, sponsored by Seoul National University. Not yet recruiting. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by Seoul National University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
All
01

Study summary

This study will examine whether light physical activity after meals can improve 24-hour glucose responses in adults with metabolic syndrome and prediabetes.

Participants will complete three experimental conditions in a randomized crossover order: prolonged sitting, 15 minutes of postprandial walking, and brief resistance exercise snacks consisting of squats and calf raises performed every 20 minutes during the postprandial period. Continuous glucose monitoring will be used to assess 24-hour glucose responses, and heart rate variability will be measured during the 2-hour postprandial period to evaluate acute autonomic responses.

The main outcome is 24-hour mean glucose derived from continuous glucose monitoring.

Read the detailed description

Metabolic syndrome and prediabetes are associated with impaired glucose regulation and increased cardiometabolic risk. Light physical activity after meals may help reduce postprandial glucose excursions and improve overall daily glucose control. However, it remains unclear whether brief resistance exercise snacks can provide glucose benefits comparable to postprandial walking under standardized meal conditions.

This study is a randomized crossover trial in adults aged 40 to 65 years with metabolic syndrome and prediabetes. Each participant will complete three experimental conditions in a randomized order: prolonged sitting, 15 minutes of walking after a standardized meal, and brief resistance exercise snacks performed every 20 minutes during the postprandial period. The resistance exercise snacks will consist of simple body-weight exercises, including squats and calf raises.

Glucose responses will be assessed using continuous glucose monitoring. The primary outcome will be 24-hour mean glucose after each experimental condition. Key secondary glycemic outcomes will include 2-hour postprandial glucose incremental area under the curve, 2-hour mean glucose, peak glucose, time to peak glucose, nocturnal mean glucose, and glycemic variability indices. Heart rate variability will be assessed during the 2-hour postprandial period using RR interval data collected with a chest strap heart rate monitor to evaluate acute autonomic responses to each condition.

The purpose of this study is to determine whether brief resistance exercise snacks can improve 24-hour glucose regulation and postprandial glucose responses compared with uninterrupted sitting, and whether these responses are comparable to postprandial walking.

02

Conditions studied

  • Metabolic Syndrome
  • Prediabetes

Keywords

  • Continuous glucose monitoring
  • Postprandial glucose
  • Exercise snack
  • Resistance exercise
  • Heart rate variability
  • Prediabetes
  • Metabolic syndrome
03

In context

Metabolic Syndrome

2,116 studies on the registry are indexed under Metabolic Syndrome; 347 are open to participants now.

This study's planned enrollment of 25 is below the median of 60 across 1,572 interventional studies indexed under Metabolic Syndrome.

Browse Metabolic Syndrome studies →

Lead sponsor

Seoul National University is the lead sponsor of 32 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Inclusion Criteria:
  • Adults aged 40 to 65 years
  • Presence of metabolic syndrome
  • Fasting glucose of 100 mg/dL or higher or of 5.7% or higher
  • Not regularly engaged in structured exercise training, defined as less than 150 minutes per week during the past year
  • Able to consume the standardized study meals
  • Able to wear a continuous glucose monitor and a chest strap heart rate monitor
  • Able to provide written

Exclusion Criteria:

  • History of major cardiovascular, cerebrovascular, respiratory, renal, hepatic, neurological, or other severe medical conditions that may affect study participation.
  • Uncontrolled hypertension, defined as systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg.
  • Current use of medications associated with a high risk of hypoglycemia, such as insulin or sulfonylureas.
  • Initiation or dose change of insulin or oral glucose-lowering medications within the past 3 months.
  • Initiation or dose change of medications for hypertension, dyslipidemia, or diabetes within the past 3 months.
  • Musculoskeletal, neurological, or orthopedic conditions that limit safe participation in walking or body-weight resistance exercise, including severe knee, hip, back, or ankle pain.
  • Regular participation in moderate-to-vigorous exercise of 150 minutes or more per week during the past year.
  • Difficulty consuming the standardized study meals, including food allergy, dietary restrictions, or severe gastrointestinal symptoms.
  • Difficulty wearing a continuous glucose monitor or history of severe skin irritation or allergy to adhesive sensors.
  • Difficulty wearing a chest strap heart rate monitor or skin problems at the chest strap site.
  • Pregnancy or planned pregnancy.
  • Acute illness, infection, surgery, or hospitalization within the past month.
  • Current participation in another interventional study.
  • Any condition judged by the investigator to make participation unsafe or inappropriate.

Exclusion Criteria:

-

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
25 participants (estimated)

Study arms

  • No intervention
    Prolonged Sitting

    Participants will remain seated during the 2-hour postprandial period after consuming a standardized meal.

  • Experimental
    Postprandial Walking

    Participants will perform 15 minutes of light-to-moderate walking after consuming a standardized meal.

    Behavioral: Postprandial walking

  • Experimental
    Brief Resistance Exercise Snacks

    Participants will perform 3-minute bouts of body-weight resistance exercises, including squats and calf raises, every 20 minutes during the postprandial period after consuming a standardized meal.

    Behavioral: Brief resistance exercise snacks

Interventions

  • BehavioralPostprandial walking

    Participants will perform 15 minutes of light-to-moderate walking after consuming a standardized meal. Walking intensity will be monitored using heart rate and rating of perceived exertion.

  • BehavioralBrief resistance exercise snacks

    Participants will perform 3-minute bouts of body-weight resistance exercises every 20 minutes during the postprandial period after consuming a standardized meal. The exercise bouts will include squats and calf raises.

06

What researchers measure

Primary outcomes

  1. 24-hour mean glucose

    Mean glucose over 24 hours after each experimental condition, derived from continuous glucose monitoring.

    Time frame: 24 hours after each experimental condition

Secondary outcomes

  1. 2-hour postprandial glucose incremental area under the curve

    The 2-hour postprandial glucose incremental area under the curve will be calculated from continuous glucose monitoring data after the standardized meal.

    Time frame: 0 to 120 minutes after the standardized meal

  2. Change in RMSSD

    Change in the root mean square of successive differences from the pre-meal resting baseline during the 2-hour postprandial period. RMSSD will be calculated from RR interval data collected with a chest strap heart rate monitor.

    Time frame: 0 to 120 minutes after the standardized meal

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07620886
Lead sponsor
Seoul National University
Responsible party
Yunmin Han (Principal Investigator, Seoul National University) — Principal investigator
First posted
Jun 2, 2026
Start date
Jun 15, 2026 (estimated)
Primary completion
Sep 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Jun 2, 2026

Study contacts

Yunmin Han
Contact
hym224@snu.ac.kr
+82-10-3537-2339

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion